Filing Flows › Mirum Pharmaceuticals (MIRM) › Free cash flow
Mirum Pharmaceuticals (MIRM) free cash flow by quarter
Mirum Pharmaceuticals' free cash flow was $5.5M in Q4 2025 (fourth quarter 2025), -86% from Q3 2025. Over the last 3 quarters it ranged from $5.5M (Q4 2025) to $39.5M (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q4 2025 | $5.5M | -86% | — |
| Q3 2025 | $39.5M | +231% | — |
| Q2 2025 | $11.9M | — | — |
Q4 2025 at a glance
Mirum Pharmaceuticals, Q4 2025: revenue $149M (+50% year over year), operating margin -3.1%, net loss $5.7M, operating cash flow $6.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Mirum Pharmaceuticals' free cash flow?
Mirum Pharmaceuticals' free cash flow was $5.5M in Q4 2025 (fourth quarter 2025), -86% from Q3 2025.
How has Mirum Pharmaceuticals' free cash flow changed?
Over the last 3 quarters it ranged from $5.5M (Q4 2025) to $39.5M (Q3 2025).